Tag: Blood Pressure

Intervention reduces sitting time at three and six months and yields reduction in systolic blood pressure at six months

Stronger association seen when sleep duration was less than five hours; women more vulnerable than men

During the same time period, the prevalence of antihypertensive medication use increased from 59.8 to 62.9 percent

Findings show link to children’s body mass index, blood pressure, total cholesterol level, and glucose level

Significant reduction seen in systolic blood pressure with zilebesiran 150, 300, 600 mg once in six months; 300 mg once every three months

Hydrochlorothiazide plus beta blockers recommended for patients with hypertension prior to BTKi initiation

Less than 20 percent of U.S. adults know their cholesterol or blood sugar levels

No increase seen in incidence of hypotension episodes with replacement of salt by potassium-enriched substitute

Reduction noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10, 15 mg tirzepatide versus placebo

Significantly higher rate seen for number of medications with at least a 30 percent reduction